| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.09 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.086 | 0.09 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.09 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |